The avian pinealocyte model is a novel system in which to explore the linkage between environmental or pharmacologic stimuli and hormone synthesis. Unlike the mammalian pineal, the avian gland is inherently photosensitive and rhythmic in its production of melatonin, expresses these characteristics either in vivo or in vitro and responds to light or catecholamines (alpha2 agonists) with an acute suppression of melatonin synthesis. This acute, inhibitory effect should also be produced by agents, such as opioid and muscarinic agonists, which disrupt cyclic AMP synthesis by mechanisms which involve the G-i class of GTP-binding proteins. Melatonin, a hormone which has anti-reproductive activity in numerous species, has also been shown to modify the analgesic responses to various opioid agents, suggesting that melatonin may be an endogenous modifier of opioid receptor activity. The primary hypothesis underlying this proposal is that the melatonin synthetic pathway is a logical target for pharmacologic agents which may exert feedback, inhibitory control on melatonin production, such as opioids. In this proposal, the effects of opioids and other related pharmacologic agents will be examined on pineal melatonin production, serotonin-N-acetyltransferase activity, cyclic AMP synthesis and light-dependent changes in G-protein subunit methylation, distribution and expression. In conclusion, as the avian pinealocyte model is both endogenously rhythmic and photosensitive, the investigations outlined in this proposal will determine whether opioid agonists and related compounds alter the pineal's acute biochemical responses and circadian behavior. As such, these studies will enhance our understanding of two critical physiological processes, response to pain and biological rhythmicity.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Research Program Projects (P01)
Project #
5P01DA008131-04
Application #
5209694
Study Section
Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Kawai, Hideki; Raftery, Michael A (2010) Kinetics of agonist-induced intrinsic fluorescence changes in the Torpedo acetylcholine receptor. J Biochem 147:743-9
Kawai, Hideki; Dunn, Susan M J; Raftery, Michael A (2008) Epibatidine binds to four sites on the Torpedo nicotinic acetylcholine receptor. Biochem Biophys Res Commun 366:834-9
Carter, Chris R J; Cao, Liren; Kawai, Hideki et al. (2007) Chain length dependence of the interactions of bisquaternary ligands with the Torpedo nicotinic acetylcholine receptor. Biochem Pharmacol 73:417-26
Conti-Fine, B M; Navaneetham, D; Lei, S et al. (2000) Neuronal nicotinic receptors in non-neuronal cells: new mediators of tobacco toxicity? Eur J Pharmacol 393:279-94
Bollweg, G L; Sparber, S B (1999) Voltage associated with spontaneous embryonic motility in the developing chicken: an automated characterization during mid-late embryogenesis. Dev Psychobiol 34:5-19
Kawai, H; Carlson, B J; Okita, D K et al. (1999) Eserine and other tertiary amine interactions with Torpedo acetylcholine receptor postsynaptic membrane vesicles. Biochemistry 38:134-41
Wei, L N; Chang, L; HU, X (1999) Studies of the type I cellular retinoic acid-binding protein mutants and their biological activities. Mol Cell Biochem 200:69-76
Schrott, L M; Sweeney, W A; Bodensteiner, K E et al. (1999) Late embryonic ritanserin exposure fails to alter normal responses to immune system stimulation in young chicks. Pharmacol Biochem Behav 64:81-8
Macklin, K D; Conti-Fine, B M (1998) Binding of single substituted promiscuous and designer peptides to purified DRB1*0101. Biochem Biophys Res Commun 242:322-6
Bollweg, G; Wei, Y X; Sparber, S B (1998) Behavioral and neuroendocrine assessment of ritanserin exposure in the developing chicken: lack of toxicity at effective doses. Pharmacol Biochem Behav 60:175-81

Showing the most recent 10 out of 50 publications